W. Wehrli
Impact in
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- DNA and Nucleic Acid Chemistry 9
- RNA and protein synthesis mechanisms 7
- Natural product bioactivities and synthesis 5
- Cancer therapeutics and mechanisms 4
- Co-authors
- M. Staehelin (12 shared papers)F. Knüsel (3 shared papers)Bruce C. Baguley (3 shared papers)H. Rogg (2 shared papers)Karl Schmid (1 shared paper)Alfred R. Schuerch (3 shared papers)T. Reichstein (8 shared papers)J. Nüesch (2 shared papers)
- Journals
- Helvetica Chimica Acta (10 papers)European Journal of Biochemistry (5 papers)Journal of the American Chemical Society (5 papers)The Journal of Antibiotics (4 papers)Biochemistry (3 papers)
- Partner nations
- SwitzerlandNew ZealandFrance
In The Last Decade
W. Wehrli
48 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 112
- Toxicology 166
- Molecular Medicine 214
- Molecular Biology 1.3k
- Infectious Diseases 339
- Pharmacology 281
Countries citing papers authored by W. Wehrli
This map shows the geographic impact of W. Wehrli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Wehrli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Wehrli more than expected).
Fields of papers citing papers by W. Wehrli
This network shows the impact of papers produced by W. Wehrli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Wehrli. The network helps show where W. Wehrli may publish in the future.
Co-authors
The 25 scholars most cited alongside W. Wehrli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 283 | |
| 2 | 1968 | 242 | |
| 3 | 1971 | 224 | |
| 4 | 1968 | 139 | |
| 5 | 1968 | 130 | |
| 6 | 1969 | 113 | |
| 7 | 1979 | 109 | |
| 8 | 1984 | 97 | |
| 9 | 1965 | 67 | |
| 10 | 1969 | 66 | |
| 11 | 1968 | 62 | |
| 12 | 1971 | 61 | |
| 13 | 1978 | 55 | |
| 14 | 2006 | 40 | |
| 15 | 1983 | 38 | |
| 16 | 1987 | 36 | |
| 17 | 1963 | 36 | |
| 18 | 1970 | 34 | |
| 19 | 1965 | 33 | |
| 20 | 1988 | 27 |
About W. Wehrli
W. Wehrli is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Biomaterials and Molecular Medicine, having authored 48 papers that have together received 2.3k indexed citations. Recurring topics across this work include DNA and Nucleic Acid Chemistry (9 papers), Phytochemistry and Bioactive Compounds (7 papers), RNA and protein synthesis mechanisms (7 papers), Antibiotic Resistance in Bacteria (6 papers), Microbial Natural Products and Biosynthesis (6 papers), Bacterial Genetics and Biotechnology (5 papers), Natural product bioactivities and synthesis (5 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Toxicology (166 citations), Molecular Medicine (214 citations), Molecular Biology (1.3k citations), Infectious Diseases (339 citations) and Pharmacology (281 citations). W. Wehrli has collaborated with scholars based in Switzerland, New Zealand and France. Frequent co-authors include M. Staehelin, F. Knüsel, Bruce C. Baguley, H. Rogg, Karl Schmid, Alfred R. Schuerch, T. Reichstein, J. Nüesch, J. G. Moffatt and J. Gruner. Their work appears in journals such as Helvetica Chimica Acta, European Journal of Biochemistry, Journal of the American Chemical Society, The Journal of Antibiotics and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.